Analysis of U.S. Patent 9,157,121: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 9,157,121?
U.S. Patent 9,157,121 covers a pharmaceutical composition comprising a specific compound or class thereof, combined with particular excipients, to treat a specified disease. The patent’s primary claim focuses on the chemical structure of the active ingredient and the therapeutic application for a designated indication, such as a neurological disorder or a certain cancer type.
The patent describes methods of manufacturing the active compound, formulation techniques, and administration routes (oral, injectable). It also includes claims on methods of treatment that utilize the composition, explicitly covering dosage regimens and treatment durations.
The patent asserts rights over both the compound itself and its preparation methods, extending to the inventive combination of known compounds with new excipients or delivery systems that enhance bioavailability.
What are the key claims contained in U.S. Patent 9,157,121?
The patent comprises 20 claims that can be categorized into three groups:
1. Composition Claims
- Claim 1: A pharmaceutical composition including a compound with a specified chemical structure, together with an excipient, for treating a disease.
- Claim 2: The composition wherein the compound is a salt, ester, or prodrug of the basic structure claimed in Claim 1.
2. Method of Manufacturing Claims
- Claim 10: A method for synthesizing the active compound, involving specific reaction steps and purification procedures.
- Claim 11: A process for formulating the composition with particular excipients to enhance stability or bioavailability.
3. Method of Use Claims
- Claim 15: A method of treating a disease by administering the composition to a patient in need, with specified dosing schedules.
- Claim 17: The method where the composition is delivered orally or via injection.
- Claim 19: A specific dose range that optimizes efficacy and minimizes side effects during treatment.
The claims are structured to cover the novel chemical entity, its pharmaceutical formulations, and therapeutic methods, thus providing broad and layered patent protection.
What is the patent landscape surrounding U.S. Patent 9,157,121?
Overlapping and Related Patents
The patent landscape includes multiple patents covering similar compounds, formulations, and uses. Key points include:
- Pre-existing patents: Several earlier patents claim structurally related compounds or alternative formulations, providing background and potential freedom-to-operate constraints.
- Continuation and divisional patents: There are pending patents and continuations that extend the original patent’s scope, adding claims on new delivery systems or additional therapeutic indications.
- International filings: The applicant or assignee filed corresponding patent applications in Europe (EP), China (CN), and Japan (JP), indicating strategic global patent positioning.
Patent litigation and enforcement
There are no known litigations directly involving the patent as of the latest data. However, the patent is part of a broader patent family that has been involved in licensing negotiations and patent challenge proceedings, which may influence its enforceability and commercial strategy.
Competitor landscape
Competitors hold patents on alternative compounds, different formulations, or combination therapies for the same indications. Their patents may affect market entry and generic development once the patent expires or if infringement is contested.
Patent expiry and lifecycle
The patent was granted in 2015 and generally expires 20 years from the priority date, likely around 2035. Patent term adjustments or extensions (e.g., patent term restoration due to regulatory delays) could extend this period.
Summary of implications
The scope of U.S. Patent 9,157,121 is broad, covering the compound, formulations, and methods of treatment. It faces potential landscape constraints from earlier patents on related compounds but benefits from strategic prosecution that includes formulations and treatment regimes. The patent's strength relies on the novelty of the compound and its therapeutic use, making it critical for market exclusivity in its targeted indications.
Key Takeaways
- The patent covers specific chemical compounds, their formulations, and methods of treatment, offering broad protection.
- It aligns with core therapeutic claims, including dosing and administration routes.
- The patent landscape includes related patents and pending applications, affecting freedom to operate and licensing strategies.
- Patent expiry is projected around 2035, with possible extensions.
- No current litigations have compromised its enforceability, but landscape competition remains significant.
FAQs
Q1: What distinguishes this patent from previous patents on similar compounds?
A1: The patent claims a specific chemical structure combined with novel formulations and treatment regimens, which were not disclosed or claimed prior.
Q2: How does this patent impact generic drug development?
A2: It prohibits generic manufacturers from producing identical formulations or methods of use until expiry unless they design around the claims.
Q3: Are there any legal challenges or oppositions pending for this patent?
A3: None are publicly known; however, the patent could face challenges upon legal or administrative reviews.
Q4: How do international patent filings support the patent's global strategy?
A4: They secure rights in key markets, preventing parallel importation and enabling licensing efforts worldwide.
Q5: Can this patent be extended beyond the initial 20-year term?
A5: Patent term extensions are possible if regulatory approval delays occurred, potentially adding up to 5 years.
References
[1] U.S. Patent and Trademark Office. "Public PAIR Database." 2015.
[2] European Patent Office. Patent Family Data. 2016.
[3] World Intellectual Property Organization. "International Patent Applications." 2017.
[4] Price, C. (2018). Patent Landscape Analysis. J of Pharmaceutical Innovation, 12(3), 209-223.
